NDC 50632-001

JYNNEOS

Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen

JYNNEOS is a Subcutaneous Injection, Suspension in the Vaccine category. It is labeled and distributed by Bavarian Nordic A/s. The primary component is Vaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen.

Product ID50632-001_3152775e-f400-4ea4-aa3d-8425450ce9a0
NDC50632-001
Product TypeVaccine
Proprietary NameJYNNEOS
Generic NameVaccinia Virus Modified Strain Ankara-bavarian Nordic Non-replicating Antigen
Dosage FormInjection, Suspension
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2021-03-17
Marketing CategoryBLA /
Application NumberBLA125678
Labeler NameBavarian Nordic A/S
Substance NameVACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN
Active Ingredient Strength50000000 1/.5mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 50632-001-02

20 VIAL in 1 CARTON (50632-001-02) > .5 mL in 1 VIAL (50632-001-01)
Marketing Start Date2021-03-17
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [JYNNEOS]

Mark Image

Registration | Serial
Company
Trademark
Application Date
JYNNEOS
JYNNEOS
79284017 not registered Live/Pending
Bavarian Nordic A/S
2020-02-28
JYNNEOS
JYNNEOS
79284016 not registered Live/Pending
Bavarian Nordic A/S
2020-02-28
JYNNEOS
JYNNEOS
79257801 5899848 Live/Registered
BAVARIAN NORDIC A/S
2019-02-27
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.